The Meta Quest 3 is the successor to the Quest 2 headset that was released in the fall of 2020 at a starting price of $299.

Quest Diagnostics: Healthier Diagnosis

02:09pm, Tuesday, 30'th May 2023
Quest Diagnostics Incorporated has seen modest growth in recent years, although serial buybacks have increased growth on a per-share basis to attractive percentages. The company has been resilient and
Quest Diagnostics' revenue and earnings fell in Q1. The company's low payout ratio should support future dividend growth.
Patients could face wait times ranging from 18 months to four years or more to get diagnosed and then treated for Alzheimer's disease.
Quest Diagnostics (DGX) base business registers growth in the first quarter of 2023.
Quest Diagnostics' (DGX) first-quarter 2023 results are likely to reflect an impressive performance in its non-COVID-19 base business amid inflationary pressure and labor challenges.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Quest Diagnostics' (DGX) upgrade to advanced diagnostics and support services is likely to feature personalized patient access to service centers and mobile phlebotomists.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

5 Upcoming Dividend Increases To Start Q2

11:47am, Thursday, 30'th Mar 2023
All these stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 10.1% and a median increase of 7.6%.
Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.
Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers
These services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE